Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+111.6%
5Y CAGR+42.5%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+111.6%/yr
Annual compound
5Y CAGR
+42.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$33.48M+1169.2%
2024$2.64M-4.4%
2023$2.76M-21.9%
2022$3.53M+551.8%
2021$-782000.00-113.7%
2020$5.70M-